RP-HPLC Analytical Method Development and Validation for Simultaneous Estimation of Three Drugs: Glimepiride, Pioglitazone, and Metformin and Its Pharmaceutical Dosage Forms

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"></td><td align="center">Linearity range</td><td align="center">Correlation coefficient</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Glimepiride</td><td align="center">50–150%</td><td align="center">0.995</td></tr><tr><td align="left">Pioglitazone</td><td align="center">50–150%</td><td align="center">0.9951</td></tr><tr><td align="left">Metformin</td><td align="center">50–150%</td><td align="center">0.992</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Journal of Chemistry

tab2

Table 2

Table 2: RP-HPLC Analytical Method Development and Validation for Simultaneous Estimation of Three Drugs: Glimepiride, Pioglitazone, and Metformin and Its Pharmaceutical Dosage Forms 

Table 2 | RP-HPLC Analytical Method Development and Validation for Simultaneous Estimation of Three Drugs: Glimepiride, Pioglitazone, and Metformin and Its Pharmaceutical Dosage Forms 